HCA Healthcare, Inc. - Common Stock (HCA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
HCA on NYSE
Shares outstanding
247,618,102
Price per share
$466.86
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
136,385,357
Total reported value
$58,107,514,730
% of total 13F portfolios
0.05%
Share change
-10,072,624
Value change
-$4,115,995,315
Number of holders
1,271
Price from insider filings
$466.86
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of HCA Healthcare, Inc. - Common Stock (HCA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 4.9% $4,064,529,812 12,133,287 BlackRock, Inc. 31 Mar 2025

As of 30 Sep 2025, 1,271 institutional investors reported holding 136,385,357 shares of HCA Healthcare, Inc. - Common Stock (HCA). This represents 55% of the company’s total 247,618,102 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of HCA Healthcare, Inc. - Common Stock (HCA) together control 36% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 6% 14,894,675 -3.8% 0.1% $6,348,110,485
BlackRock, Inc. 5% 12,467,326 -3.7% 0.09% $5,313,574,326
Sanders Capital, LLC 4.3% 10,675,663 -3.8% 5.6% $4,549,967,571
STATE STREET CORP 3% 7,490,604 -5.9% 0.11% $3,192,495,425
Capital World Investors 2% 4,959,336 +3.8% 0.29% $2,113,661,728
First Eagle Investment Management, LLC 1.6% 3,919,472 -6.9% 3% $1,670,478,761
WELLINGTON MANAGEMENT GROUP LLP 1.6% 3,880,196 -5.6% 0.29% $1,653,739,536
GEODE CAPITAL MANAGEMENT, LLC 1.5% 3,650,140 -3.9% 0.1% $1,547,861,523
JPMORGAN CHASE & CO 1.2% 2,987,069 -8.9% 0.08% $1,273,089,601
MORGAN STANLEY 0.86% 2,129,892 -4.5% 0.05% $907,760,960
BANK OF AMERICA CORP /DE/ 0.84% 2,072,844 -9.7% 0.07% $883,445,983
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.83% 2,065,225 +1.8% 0.56% $880,198,895
FMR LLC 0.77% 1,905,133 +19% 0.04% $811,968,123
NORTHERN TRUST CORP 0.73% 1,819,159 -4.2% 0.1% $775,325,567
GOLDMAN SACHS GROUP INC 0.73% 1,812,212 +10% 0.11% $772,364,951
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC 0.69% 1,716,415 -13% 0.16% $731,536,073
UBS Group AG 0.65% 1,602,599 +2.4% 0.13% $683,027,693
Nuveen, LLC 0.61% 1,521,470 -7.5% 0.17% $648,450,513
VIKING GLOBAL INVESTORS LP 0.56% 1,380,583 -26% 1.5% $588,404,475
JANUS HENDERSON GROUP PLC 0.5% 1,242,882 -1.6% 0.24% $529,720,228
BARCLAYS PLC 0.5% 1,230,892 -2.4% 0.2% $524,606,169
FRANKLIN RESOURCES INC 0.47% 1,173,404 -18% 0.13% $500,104,784
Bank of New York Mellon Corp 0.46% 1,126,683 -2% 0.09% $480,192,285
Legal & General Group Plc 0.45% 1,124,511 +0.76% 0.11% $479,266,586
Invesco Ltd. 0.44% 1,100,929 +1.1% 0.07% $469,215,948

Institutional Holders of HCA Healthcare, Inc. - Common Stock (HCA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 1,958,449 $917,976,074 +$91,596,664 $466.86 78
2025 Q3 136,385,357 $58,107,514,730 -$4,115,995,315 $426.20 1,271
2025 Q2 146,598,810 $56,127,057,771 -$1,853,153,884 $383.10 1,239
2025 Q1 152,067,797 $52,521,133,903 -$2,008,026,227 $345.55 1,210
2024 Q4 158,335,395 $47,536,161,067 +$853,490,169 $300.15 1,154
2024 Q3 154,689,529 $62,797,811,143 -$3,682,187,301 $406.43 1,191
2024 Q2 163,826,521 $52,661,256,868 +$670,962,780 $321.28 1,149
2024 Q1 161,413,351 $53,789,492,029 -$1,785,168,882 $333.53 1,112
2023 Q4 1,500,611 $406,043,029 +$14,484,613 $270.68 13
2023 Q3 166,313,392 $40,909,070,761 -$1,222,239,672 $245.98 976
2023 Q2 168,987,433 $51,216,927,639 -$1,365,819,378 $303.48 994
2023 Q1 170,391,002 $44,919,179,500 -$775,563,238 $263.68 948
2022 Q4 177,496,235 $42,598,746,044 -$1,078,246,139 $239.96 936
2022 Q3 183,957,927 $33,836,311,737 -$787,395,132 $183.79 833
2022 Q2 188,166,842 $31,630,506,396 -$1,603,447,486 $168.06 841
2022 Q1 195,140,284 $48,931,872,740 -$1,558,681,909 $250.62 934
2021 Q4 197,985,153 $50,846,454,867 -$1,509,472,151 $256.92 923
2021 Q3 209,919,404 $50,958,738,158 -$2,689,041,629 $242.72 863
2021 Q2 221,124,024 $45,726,509,754 -$1,464,835,996 $206.74 802
2021 Q1 230,469,043 $43,379,991,616 -$1,181,020,324 $188.34 769
2020 Q4 236,714,825 $38,921,695,317 +$205,518,531 $164.46 757
2020 Q3 233,135,949 $29,057,018,783 +$360,426,507 $124.68 702
2020 Q2 233,494,211 $22,650,901,376 +$83,149,363 $97.06 667
2020 Q1 230,886,120 $20,747,266,126 -$446,572,792 $89.85 680
2019 Q4 237,527,332 $35,063,523,936 +$67,604,438 $147.81 701
2019 Q3 237,385,671 $28,547,954,761 -$508,575,220 $120.42 666
2019 Q2 239,521,942 $32,317,567,027 +$720,584,626 $135.17 661
2019 Q1 239,204,677 $31,136,661,362 -$286,192,396 $130.38 686
2018 Q4 241,301,684 $29,977,465,549 +$101,787,070 $124.45 684
2018 Q3 242,695,804 $33,692,374,101 -$374,970,122 $139.12 641
2018 Q2 243,682,594 $24,948,781,554 -$134,898,147 $102.60 633
2018 Q1 247,430,485 $23,934,304,006 -$632,738,587 $97.00 599
2017 Q4 254,047,937 $22,259,361,383 -$1,108,374,922 $87.84 550
2017 Q3 264,433,849 $21,044,735,570 -$4,516,181 $79.59 515
2017 Q2 265,897,396 $23,189,075,221 -$197,325,383 $87.20 558
2017 Q1 271,479,436 $24,158,212,024 +$1,674,716,109 $88.99 563
2016 Q4 273,642,281 $20,250,403,747 +$131,173,251 $74.02 558
2016 Q3 271,566,604 $20,527,128,085 -$505,241,924 $75.63 573
2016 Q2 277,597,809 $21,377,824,822 -$919,881,573 $77.01 603
2016 Q1 289,921,129 $22,623,067,519 -$244,974,576 $78.05 579
2015 Q4 296,390,984 $20,046,285,881 -$1,047,785,968 $67.63 575
2015 Q3 309,412,323 $23,931,783,528 -$361,133,065 $77.36 625
2015 Q2 306,751,024 $27,827,934,316 -$608,894,910 $90.72 646
2015 Q1 320,635,747 $24,119,714,997 +$183,965,275 $75.23 585
2014 Q4 318,077,983 $23,344,931,320 -$895,722,000 $73.39 537
2014 Q3 329,374,989 $23,228,238,725 +$553,281,484 $70.52 496
2014 Q2 323,319,890 $18,233,917,231 -$762,117,190 $56.38 434
2014 Q1 337,793,920 $17,729,830,260 +$345,174,496 $52.50 397